These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3796218)

  • 1. Preferential release of oxytocin in response to vasoactive intestinal polypeptide in rats.
    Bardrum B; Ottesen B; Fuchs AR
    Life Sci; 1987 Jan; 40(2):169-73. PubMed ID: 3796218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
    Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
    Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from the neurohypophyis.
    Ottesen B; Hansen B; Fahrenkrug J; Fuchs AR
    Endocrinology; 1984 Oct; 115(4):1648-50. PubMed ID: 6479104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
    Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
    Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat.
    Poole CJ; Carter DA; Vallejo M; Lightman SL
    J Endocrinol; 1987 Jan; 112(1):97-102. PubMed ID: 2950195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual dimorphism in the posterior pituitary response to stress in the rat.
    Williams TD; Carter DA; Lightman SL
    Endocrinology; 1985 Feb; 116(2):738-40. PubMed ID: 3967625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
    Ciosek J
    J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous infusion of substance P on arginine vasopressin and oxytocin secretion in normal men.
    Chiodera P; Coiro V
    Brain Res; 1992 Jan; 569(1):173-6. PubMed ID: 1377080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin.
    Schriefer JA
    Neuroendocrinology; 1991 Sep; 54(3):185-91. PubMed ID: 1682832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Brain Res; 1986 Sep; 382(2):352-9. PubMed ID: 3756522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin, vasoactive-intestinal peptide, and serotonin regulate the mating-induced surges of prolactin secretion in the rat.
    Arey BJ; Freeman ME
    Endocrinology; 1990 Jan; 126(1):279-84. PubMed ID: 2136724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion.
    Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J
    Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of oxytocin and vasopressin release from rat neurosecretosomes: the roles of VIP oxytocin and GABA.
    Falke N
    Neuropeptides; 1991 Mar; 18(3):143-7. PubMed ID: 2067599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats.
    Murase T; Kondo K; Otake K; Oiso Y
    Neuroendocrinology; 1993 Jun; 57(6):1092-6. PubMed ID: 7901784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man.
    Chiodera P; Volpi R; Capretti L; Coiro V
    Neuroreport; 1995 Jul; 6(11):1490-2. PubMed ID: 7579131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies.
    Hyde JF; Ben-Jonathan N
    Endocrinology; 1989 Aug; 125(2):736-41. PubMed ID: 2526728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-mediated inhibition of oxytocin during insulin-induced hypoglycemic stimulation of vasopressin in man.
    Seckl JR; Haddock JA; Dunne MJ; Lightman SL
    Acta Endocrinol (Copenh); 1988 May; 118(1):77-81. PubMed ID: 2838996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of endogenous and exogenous oestrogens on posterior pituitary secretion in women.
    Williams TD; Edwards A; Fairhall KM; Robinson IC; McGarrick GM; Lightman SL
    Clin Endocrinol (Oxf); 1985 May; 22(5):589-96. PubMed ID: 4028458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.